Literature DB >> 18429736

Models of chronic disease management in primary care for patients with mild-to-moderate asthma or COPD: a narrative review.

Josephine M Cranston1, Alan J Crockett, John R Moss, Robert W Pegram, Nigel P Stocks.   

Abstract

OBJECTIVE: To review the literature for any promising strategies for the primary care management of mild-to-moderate asthma and chronic obstructive pulmonary disease (COPD) in adults.
METHODS: Using "MeSH" terms for COPD, asthma and primary health care, we conducted an extensive literature search for relevant meta-analyses, systematic reviews, narrative reviews, reports and individual studies. Grey literature was also included. We chose a narrative review approach because of substantial heterogeneity of study designs in the literature.
RESULTS: 1119 articles of potential relevance were retained, of which 246 were included in our review. There was insufficient evidence to determine whether general practitioners with a special interest (GPwSI) in respiratory care improved the diagnosis and management of mild-to-moderate COPD. An asthma service involving GPwSI increased respiratory drug costs but reduced the costs for less specific drugs. No clear benefit has been shown for practice nurse-run asthma clinics in primary care compared with usual care in altering asthma morbidity, quality of life, lung function or medication use. Evidence to determine the effectiveness of practice nurse-run COPD clinics could not be found. Self-management education, GP review and action plans may produce short-term benefits for asthma patients, particularly those with moderate-to-severe disease, but the evidence for a similar approach to patients with mild-to-moderate COPD is equivocal. There has been poor uptake of respiratory clinical guidelines relevant to primary care - partly because most guidelines are based on moderate-to-severe disease. Spirometry programs in primary care are useful for differential diagnosis of asthma and COPD. Spirometry may alter the management of mild asthma, but there is a lack of evidence that it alters the management of COPD in primary care.
CONCLUSION: The role of primary health care in management of mild-to-moderate asthma and COPD requires further investigation using randomised controlled trials.

Entities:  

Mesh:

Year:  2008        PMID: 18429736     DOI: 10.5694/j.1326-5377.2008.tb01744.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

1.  Regular primary care lowers hospitalisation risk and mortality in seniors with chronic respiratory diseases.

Authors:  Kristjana Einarsdóttir; David B Preen; Jon D Emery; Christopher Kelman; C D'Arcy J Holman
Journal:  J Gen Intern Med       Date:  2010-04-28       Impact factor: 5.128

2.  Mortality in Western Australian seniors with chronic respiratory diseases: a cohort study.

Authors:  Kristjana Einarsdóttir; David B Preen; Frank M Sanfilippo; Raylene Reeve; Jon D Emery; C D'Arcy J Holman
Journal:  BMC Public Health       Date:  2010-07-01       Impact factor: 3.295

3.  Consultation performance of general practitioners when supported by an asthma/COPDC-service.

Authors:  Lucas E M Annelies; Derckx W C C Emmy; Meulepas A Marianne; Smeele J M Ivo; Smeenk W J M Frank; van Schayck P Onno
Journal:  BMC Res Notes       Date:  2012-07-23

4.  Why is spirometry underused in the diagnosis of the breathless patient: a qualitative study.

Authors:  Nicola J Roberts; Susan F Smith; Martyn R Partridge
Journal:  BMC Pulm Med       Date:  2011-06-16       Impact factor: 3.317

5.  Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial.

Authors:  Erik W M A Bischoff; Reinier Akkermans; Jean Bourbeau; Chris van Weel; Jan H Vercoulen; Tjard R J Schermer
Journal:  BMJ       Date:  2012-11-28

6.  A new model of integrated primary-secondary care for complex diabetes in the community: study protocol for a randomised controlled trial.

Authors:  Jianzhen Zhang; Letitia Burridge; Kimberley A Baxter; Maria Donald; Michele M Foster; Samantha A Hollingworth; Robert S Ware; Anthony W Russell; Claire L Jackson
Journal:  Trials       Date:  2013-11-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.